ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Kidney Week 2020 Reimagined: Exhibitor Spotlight Schedule

On-Demand October 22 - December 4, 2020

Hear from leading experts on the latest advances in nephrology practices, therapies, services, and technologies. Available through December 4, click the Exhibits and Spotlights Tab on the Kidney Week 2020 Reimagined homepage to access these presentations at your convenience.

A Novel Approach to Anemia - Introducing HIF SoPHIstication
Supported by Akebia Therapeutics, Inc.

Oxalate and the Kidneys: Primary Hyperoxaluria in Practice
Supported by Alnylam Pharmaceuticals

Shortening the Journey to Fabry Disease Diagnosis - Perspectives from a Patient and Nephrologist
Supported by Amicus Therapeutics

Advancing the Science of Phosphate Absorption: Paracellular Pathway and Implications for Phosphorus Management
Supported by Ardelyx

The Efficacy and Safety of LOKELMA® (sodium zirconium cyclosilicate)
Supported by AstraZeneca

Anemia of CKD: A Changing Perspective Based on the HIF Pathway
Supported by AstraZeneca

Lupus Nephritis: The Importance of Active Surveillance, Early Diagnoses, and Successful Treatment
Supported by Aurinia Pharmaceuticals

Where There's Smoke, There's Fire: Uncovering the Role of Inflammation and Fibrosis in CKD Progression in T2D
Supported by Bayer

Understanding the Interconnectivity of the CV, Renal, and Metabolic Systems
Supported by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA

AlloSure as a Tool for Surveillance of Renal Transplant Patients: Real World Evidence and Clinical Utility
Supported by CareDx

Rethinking Fabry Disease: Reasons to Look into the Future
Supported by Chiesi Global Rare Diseases

Lupus Nephritis: The CASE for Early Recognition and Management
Supported by GSK

Discover the Genetic Etiology of Kidney Disease with Renasight
Supported by Natera

IgA Nephropathy - Understanding the Role of the Complement Pathway
Supported by Novartis

IgA Nephropathy: Pathophysiology, Therapeutic Advances, and Ongoing Clinical Trials
Supported by Omeros Corporation

Taking the Next Step in the Management of ADPKD: Insights from a Multidisciplinary Panel
Supported by Otsuka America Pharmaceutical, Inc.

Understanding Innovative Endpoints in Glomerular Diseases
Supported by Retrophin

Minimize Risk of Iron Overload: Centralize Delivery With a Novel Approach to Anemia Management in Hemodialysis
Supported by Rockwell Medical

Evolving Concepts in ADPKD
Supported by Sanofi Genzyme

Renal Phosphate Wasting Disorders: X-Linked Hypophosphatemia (XLH) and Tumor-Induced Osteomalacia (TIO)
Supported by Ultragenyx Pharmaceutical Inc.

The Exhibitor Spotlights are not Continuing Education (CE) activities.

*Additional information included by clicking on title if provided by supporter.